CASP3 and melanoma: The intranasal administration of Pulmozyme® (100 U/mouse) to B16 melanoma-bearing mice did not change the expression of caspase-3 and enhanced the expression of caspase-7 by 21% in lung metastasis foci compared to the control group (Figures S2A,B, S3 and S4).